参考文献/References:
[1] 中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):292-344.DOI:10.19538/j.nk2018040108.
[2] Cao H.Adipocytokines in obesity and metabolic disease[J].J Endocrinol,2014,220(2):T47-T59.DOI:10.1530/JOE-13-0339.
[3] Rosen ED,Spiegelman BM.What we talk about when we talk about fat?[J].Cell,2014,156(1-2):20-44.DOI:10.1016/j.cell.2013.12.012.
[4] Romere C,Duerrschmid C,Bournat J,et al.Asprosin, a fasting-induced glucogenic protein hormone[J].Cell,2016,165(3):566-579.DOI:10.1016/j.cell.2016.02.063.
[5] Duerrschmid C,He Y,Wang C,et al.Asprosin is a centrally acting orexigenic hormone[J].Nat Med,2017,23(12):1444-1453.DOI:10.1038/nm.4432.
[6] 胰岛素抵抗及其在2型糖尿病发病机制中的作用//Ronald Kahn,Gordon G. Weir,主编. 潘长玉,主译. JOSLIN糖尿病学[M]. 第14版. 北京:人民卫生出版社,2007:447-449
[7] O'Neill B,Simha V,Kotha V,et al.Body fat distribution and metabolic variables in patients with neonatal progeroid syndrome[J].Am J Med Genet A,2007,143A(13):1421-1430. DOI:10.1002/ajmg.a.31840.
[8] Zhang X,Jiang H,Ma X,et al.Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus[J].J Diabetes Investig,2019,[Epub ahead of print].DOI:10.1111/jdi.13148.
[9] Wang Y,Qu H,Xiong X,et al.Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion[J].Mediators Inflamm,2018,2018:9471583.DOI:10.1155/2018/9471583.
[10] 李昊翔,徐梦娇,袁婧,等.2型糖尿病合并非酒精性脂肪肝患者血清白脂素浓度变化及其影响因素[J].江苏大学学报(医学版),2019,29(1):62-66. DOI:10.13312/j.issn.1671-7783.y180227.
[11] Glen J,Floros L,Day C,et al.Non-alcoholic fatty liver disease(NAFLD): summary of NICE guidance[J].BMJ,2016,354:i4428.DOI:10.1136/bmj.i4428.
[12] Beutler LR,Knight ZA.A spotlight on appetite[J].Neuron,2018,97(4):739-741.DOI:10.1016/j.neuron.2018.01.050.
[13] Jacobi D,Liu S,Burkewitz K,et al.Hepatic bmal1 regulates rhythmic mitochondrial dynamics and promotes metabolic fitness[J].Cell Metab,2015,22(4):709-720.DOI:10.1016/j.cmet.2015.08.006.
[14] Li E,Shan H,Chen L,et al.OLFR734 mediates glucose metabolism as a receptor of asprosin[J].Cell Metab,2019,30(2):319-328.e8.DOI:10.1016/j.cmet.2019.05.022.
[15] Morton GJ,Schwartz MW.The NPY/AgRP neuron and energy homeostasis[J].Int J Obes Relat Metab Disord,2001,25(Suppl 5):S56-S62.DOI:10.1038/sj.ijo.0801915.
[16] Jung TW,Kim HC,Kim HU,et al.Asprosin attenuates insulin signaling pathway through PKCδ-activated ER stress and inflammation in skeletal muscle[J].J Cell Physiol,2019,234(11):20888-20899.DOI:10.1002/jcp.28694.
[17] Salvadó L,Barroso E,Gómez-Foix AM,et al.PPARβ/δ prevents endoplasmic reticulum stress-associated inflammation and insulin resistancein skeletal muscle cells through an AMPK-dependent mechanism[J].Diabetologia,2014,57(10):2126-2135.DOI:10.1007/s00125-014-3331-8.
[18] Lee T,Yun S,Jeong JH,et al.Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation[J].Mol Cell Endocrinol,2019,486:96-104.DOI:10.1016/j.mce.2019.03.001.
[19] Friesen M,Cowan CA.Adipocyte metabolism and insulin signaling perturbations: insights from genetics[J].Trends Endocrinol Metab,2019,30(6):396-406.DOI:10.1016/j.tem.2019.03.002.
[20] Wang M,Yin C,Wang L,et al.Serum asprosin concentrations are increased and associated with insulin resistance in children with obesity[J].Ann Nutr Metab,2019,75(4):205-212.DOI:10.1159/000503808.
[21] Low Wang CC,Hess CN,Hiatt WR,et al.Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus-mechanisms, management,and clinical considerations[J].Circulation,2016,133(24):2459-2502. DOI:10.1161/CIRCULATIONAHA.116.022194.
[22] Ouchi N.Adipocytokines in cardiovascular and metabolic diseases[J].J Atheroscler Thromb,2016,23(6):645-654.DOI:10.5551/jat.34918.
[23] Dobiásová M.Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications[J].Clin Chem,2004,50(7):1113-1115.DOI:10.1373/clinchem.2004.033175.
[24] 徐佰达,叶挺,王倩. 血浆白脂素水平与冠心病的关系[J].心脏杂志, 2019,31(4):428-431.DOI:10.12125/j.chj.201902048.
[25] 陈莎,汪雄,邱琛茗,等.Spartin和白脂素在糖尿病心脏微血管内皮损伤中的作用及其机制探讨[J].四川大学学报(医学版),2019,50(6):827-834.
[26] Ugur K,Aydin S.Saliva and blood asprosin hormone concentration associated with obesity[J].Int J Endocrinol,2019,2019:2521096.DOI:10.1155/2019/2521096.
[27] Zhang L,Chen C,Zhou N,et al.Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride[J].Clin Chim Acta,2019,489:183-188.DOI:10.1016/j.cca.2017.10.034.
[28] Alan M,Gurlek B,Yilmaz A,et al.Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome[J].Gynecol Endocrinol,2019,35(3):220-223.DOI:10.1080/09513590.2018.1512967.
相似文献/References:
[1]赵紫琴,雒瑢,田凤石,等.替米沙坦对OLETF大鼠皮下和内脏脂肪组织PPARγ表达的影响[J].国际内分泌代谢杂志,2014,(06):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
Zhao Ziqin*,Luo Rong,Tian Fengshi,et al.Effects of telmisartan on expression of PPARγ in subcutaneous and visceral adipose tissue in OLETF rats[J].International Journal of Endocrinology and Metabolism,2014,(04):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
[2]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(04):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
[3]曹萌 韦晓 刘超.自噬与胰岛β细胞功能及2型糖尿病[J].国际内分泌代谢杂志,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
Cao Meng,Wei Xiao,Liu Chao..Relationship between autophagy and islet β cells function, type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(04):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
[4]刘艳 田秀标 韩颖.GLP-1受体激动剂呈葡萄糖依赖性刺激胰岛β细胞胰岛素分泌的机制[J].国际内分泌代谢杂志,2015,(01):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
Liu Yan*,Tian Xiubiao,Han Ying..Mechanism of GLP-1 receptor agonists in the stimulation of insulin secretion of islet β cell in a glucose-dependent manner[J].International Journal of Endocrinology and Metabolism,2015,(04):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
[5]齐利琴,刘礼斌.GLP-1在2型糖尿病诱发的阿尔茨海默病治疗中的作用[J].国际内分泌代谢杂志,2016,36(01):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
Qi Liqin,Liu Libin..Effects of GLP-1 in the treatment of Alzheimer's disease induced by type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(04):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
[6]梅稳,向光大,卢俊颜,等.GDF11对ApoE-/-糖尿病小鼠内皮依赖性
血管舒张功能的作用[J].国际内分泌代谢杂志,2016,36(02):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
Mei Wen*,Xiang Guangda,Lu Junyan,et al.Effects of GDF11 on endothelium-dependent vasodiation function of aorta in ApoE-/- diabetic mice[J].International Journal of Endocrinology and Metabolism,2016,36(04):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
[7]殷俏,张云良,郭淑芹,等.视黄醇结合蛋白4、超敏C反应蛋白
与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
Yin Qiao,Zhang Yunliang,Guo Shuqin,et al.Relationship of retinol binding protein 4 and high sensitive C-reactive protein with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2016,36(04):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
[8]王涛,张洁,祁范范,等.不同糖耐量人群血清25(OH)D3水平
及与胰岛β细胞功能的关系[J].国际内分泌代谢杂志,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
Wang Tao*,Zhang Jie,Qi Fanfan,et al.Relationship between serum 25(OH)D3 level and islet β cell function in individuals with different glucose tolerance[J].International Journal of Endocrinology and Metabolism,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
[9]陈双双,王楚媛,孔令芳.铬与2型糖尿病[J].国际内分泌代谢杂志,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
Chen Shuangshuang,Wang Chuyuan,Kong Lingfang.Chromium and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
[10]涂萍,许婷,段鹏,等.25-羟维生素D3补充对绝经后2型糖尿病
患者胰岛素敏感性及血糖控制的影响[J].国际内分泌代谢杂志,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]
Tu Ping,Xu Ting,Duan Peng,et al.Influence of 25-hydroxyvitamin D3 supplement on insulin sensitivity and glucose control in postmenopausal patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(04):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]
[11]沙宇菁,李彦彦,杨玲.白脂素与2型糖尿病及其血管并发症的研究进展[J].国际内分泌代谢杂志,2021,41(02):133.[doi:10.3760/cma.j.cn121383-20200603-06007]
Sha Yujing,Li Yanyan,Yang Ling.Research progress of asprosin in type 2 diabetes mellitus and its vascular complications[J].International Journal of Endocrinology and Metabolism,2021,41(04):133.[doi:10.3760/cma.j.cn121383-20200603-06007]